Events

Saturday, June 1, 2024 – 8:00 am - 5:00 pm

ALL PRESENTATIONS ARE APPLICATION-BASED ACTIVITIES
 

7:00 am - 8:00 am  Registration / Welcome / Announcements

8:00 am - 9:00 am  Updates in Pharmacy Law (0.1 CEUs) by Kim Sveska, RPh, MS, JD

ACPE Universal Activity Number: 

• Describe changes in Michigan statutes and administrative rules affecting pharmacy practice.
• List ethical and potential legal issues relating to dispensing controlled substances.
• Discuss examples of ethics cases discussed during the presentation.
• Recognize areas which present pharmacists and technicians with ethical obligations to patients.

9:00 am - 11:00 am  Implicit Bias Training for the Pharmacy Healthcare Professional  (0.2 CEUs) by Aline Saad, PharmD 

ACPE Universal Activity Number: 

• Describe Implicit Bias, how it is acquired, and how it affects our beliefs about others.
• Define health disparities and the social determinants of health. 
• Explain the impact of Implicit Bias on patient care.
• Discuss strategies to minimize Implicit Bias in healthcare practice and teams.

11:00 am - 12:00 am  Compounding Pharmacy: A Renaissance in the Making  (0.1 CEUs) by Joan Erebor, PhD, MPhil, BPharm, CAPM, PMP 

ACPE Universal Activity Number: 

• Discuss the current trends in compounding pharmacy.
• Recognize the impact that compounding pharmacy is making in the supply chain of medications.
• Identify the types of compounding pharmacy set ups. 
• Identify risks involved with compounding pharmacy, compounded medications, and identify ways to mitigate the risk.
• Recognize FDA level of involvement in compounding pharmacy. 
• Discuss the role of pharmacists in the renaissance of compounding pharmacy.
   

12:00 pm - 1:00 pm  LUNCH BREAK

1:00 pm - 2:00 pm  Practical Pain Management (0.1 CEUs) by Chijioke C. Nwagwu, DO

ACPE Universal Activity Number: 

• Identify and differentiate between various types of pain, such as acute, chronic, nociceptive, and neuropathic pain.
• Describe the various pharmacologic treatments for pain, including their mechanisms, indications, and potential side effects.
• Discuss non-pharmacologic pain management strategies, including physical therapy, cognitive-behavioral therapy, and complementary therapies.

2:00 pm - 3:00 pm  What is Known About Psychoactive Substances in Pain Management? (0.1 CEUs) by Tara Nichols, DNP, ARNP, CCNS, AGCNS, PMGT-BC

ACPE Universal Activity Number: 

• Define novel psychoactive substances and "legal highs."
• Discuss substance profiles of opioid and non-opioid related novel psychoactive substances.
• Identify important safety concerns for substances potentially seen in pain management.

3:00 pm - 5:00 pm  Current Updates in Stroke and Hypertrophic Cardiomyopathy (0.2 CEUs) by Leo Egbujiobi, RPh, MD  

ACPE Universal Activity Number: 

Stroke

• Distinguish the different subtypes of stroke.
• Discuss diagnostic tools used to evaluate patients with a clinical diagnosis of stroke.
• Explain vascular risk factor management recommendations for smoking/substance use,  hypertension, dyslipidemia, diabetes, obesity, sleep apnea, intracranial large artery atherosclerosis, and extracranial large artery atherosclerosis.
• Describe stroke management recommendations, including antithrombotic regimen.
• Discuss secondary stroke prevention in special situations, including prosthetic valves, cardiomyopathy, PFO, hypercoagulable states, and genetic disorders.

Hypertrophic Cardiomyopathy

• Identify characteristics of hypertrophic cardiomyopathy, including definition, inheritance pattern, disease prevalence,  and differential diagnoses.
• Describe adverse events associated with hypertrophic cardiomyopathy.
• Explain the pathophysiologic myocardial changes that occur in hypertrophic cardiomyopathy.
• Describe screening and evaluation recommendations for hypertrophic cardiomyopathy.
• Explain indications for ICD placement in hypertrophic cardiomyopathy.
• Discuss management of hypertrophic cardiomyopathy, including pharmacologic and invasive options.
• Identify lifestyle recommendations for hypertrophic cardiomyopathy.

5:00 pm.  Questions and Post-CE Evaluation

Pharmacists and Healthcare Professionals

Registration Fee  $175

Chinyere Anyanwu, PharmD

gathanyanwu@yahoo.com

(313) 354-2073

Rogers Elebra, PharmD, MS, MBA

elebraone@aol.com

(313) 550-4460

Kene Monplaisir, PharmD

kstar8859@gmail.com

(734) 552-6533

Leo Egbujiobi, RPh, MD 

• Director of Cardiology, Beloit Memorial Hospital, Beloit, Wisconsin
• Clinical Professor of Medicine, University of Wisconsin Medical School, Madison, Wisconsin

Joan O. Erebor PhD, MPhil, BPharm, CAPM, PMP 

• Founder & CEO MAFEREB LLC 

Tara Nichols, DNP, ARNP, CCNS, AGCNS, PMGT-BC

• Research Nurse Care Manager, CORP
• Tele-Collaborative Outreach to Rural Patients with Chronic Pain 

Chijoke C. Nwagwu, DO

• Physiatrist, Rehabilitation Physicians, PC
• Board-Certified, American Board of Physical Medicine & Rehabilitation Physicians

 Aline Saad, PharmD 

• Clinical Associate Professor, Director of Faculty Development, Coordinator of Interprofessional Education, IPE Faculty Champion- MI AHEC

Kim Sveska, RPh, MS, JD

• Attorney / Corporate Council, Foley, Baron, Metzger, & Juip, PLLC, Livonia, Michigan